Dersimelagon
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dersimelagon, covering 2025-12-11 to 2025-12-11. Get the full timeline:
Most recent: Clinical Trial Update: Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP) [Phase 3]